Pemigatinib for the treatment of myeloid/lymphoid neoplasms with <i>FGFR1</i> rearrangement-Reference-Cited by-同舟云学术

Pemigatinib for the treatment of myeloid/lymphoid neoplasms with FGFR1 rearrangement

Published:2023-03-29 Issue:4 Volume:23 Page:351-359
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Freyer Craig W.¹²^ORCID,Hughes Mitchell E.¹³^ORCID,Carulli Alison¹^ORCID,Bagg Adam⁴,Hexner Elizabeth²^ORCID

Affiliation:

1. Department of Pharmacy Services, Hospital of the University of Pennsylvania, Philadelphia, PA, USA

2. Department of Medicine, Division of Hematology/Oncology, Perelman School of Medicine and the Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, PA, USA

3. Lymphoma Program, Hematology/Oncology Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

4. Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA

Funder

The authors have no funding to report

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2023.2192930

Reference54 articles.

1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

2. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

3. Myeloid/lymphoid neoplasms withFGFR1rearrangement

4. 8p11 myeloproliferative syndrome: a review

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision oncology targeting FGFRs: A systematic review on pre-clinical activity and clinical outcomes of pemigatinib;Critical Reviews in Oncology/Hematology;2024-10

2. Differentialdiagnose der Eosinophilie aus hämatologischer Sicht;Aktuelle Rheumatologie;2024-05-16

3. Acute myeloid leukemia with LRRFIP1::FGFR1 rearrangement and a complex karyotype;Cancer Genetics;2023-11

4. Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment;Biomedicines;2023-09-27